| News Title |
|
|
|
|
 |
*** DRUG SHORTAGE INFORMATION ***
DIAMORPHINE INJECTION
It is anticipated that there will be a stock shortage of diamorphine 5mg and 10mg injection from March 2020 that may not resolve until summer 2020. Further detailed information about this issue and alternatives can be found at this link and from the diamorphine entry within this formulary.
27/02/2020 |
|
|
|
|
|
***DRUG SHORTAGE INFORMATION***
CLONIDINE 25 MICROGRAM TABLETS
There is a long term supply issue with clonidine 25 microgram tablets. No resolution date is yet known. Please see the medicines shortage bulletin for more information.
Abrupt withdrawl is not recommended due to the severe risk of rebound hypertension. Cases of agitation, restlessness, palpitations, nervousness, tremor, headache and abdominal symptoms have also been reported.
31/01/2020 |
|
|
|
|
|
***DRUG RECALL INFORMATION***
Emerade (adrenaline) 150, 300, 500 microgram autoinjector devices recall: All batches of Emerade have been recalled and no further stocks will be available in the foreseeable future. Staff are advised to use adrenaline ampoules for intramuscular administration when needed.
02/12/2019 |
|
|
|
|
|
***TEMPORARY DRUG SHORTAGE INFORMATION***
MOCLOBEMIDE
There is a temporary manufacturing supply issue with moclobemide affecting both strengths (150mg and 300mg).
- One manufacturer is out of stock of both stengths and does not have a date for resupply.
- The other currently has stocks of 150mg but the 300mg are currently out of stock and not expected back into stock until early next year.
29/11/2019 |
|
|
|
|
|
Delmosart 18mg is out of stock again resolution date expected to be 18/11/19. All other strengths remain available. Recommended alternatives to use until the issue is resolved are Xaggitin or Concerta XL.
17/10/2019 |
|
|
|
|
|
Supply issue RESOLVED: Delmosart 18mg and 27mg strengths will be back in stock at wholesalers from today (5th August).
05/08/2019 |
|
|
|
|
|
The July 2019 Drugs & Therapeutics Group Bullet Point summary includes links to updated and new policies, guidelines, shared care protocols, new drugs, drug shartages and more. Please click on this link to open the 3 page summary.
01/08/2019 |
|
|
|
|
|
Cariprazine has been added to the formulary as a restricted medicine. It can be used in patients with schizophrenia as a second line treatment where negative symptoms predominate. For further information about the DTG decision and restriction and for prescribing information click here.
01/08/2019 |
|
|
|
|
|
***TEMPORARY DRUG SHORTAGE*** Delmosart 18mg and 27mg tablets are temporarily unavailable. The 36mg and 54mg remain available. The manufacturer describes the shortage as short term, but is unable to provide a resolution date currently. Updates will be posted here when known. Bioequivalent alternatives that could be prescribed in the interim include Xaggitin XL or Concerta XL.
17/07/2019 |
|
|
|
|
|
Shared Care Best Practice Guideline - Oxfordshire CCG has published a joint document with the OUH and Oxford Health that aims to improve the communication of shared care.
16/07/2019 |
|
|
|
|
|
Phenelzine shortage: the sole manufacturer of phenelzine has announced that they will be out of stock of phenelzine between August and at least October. There are more details available on the Specialist Pharmacy Services website and we will add all updates to our formulary pages.
15/07/2019 |
|
|
|
|
|
Updated OHFT Behavioural and Psychological Symptoms of Dementia (BPSD) guideline now available. Click here.
01/07/2019 |
|
|
|
|
|
There is currently a shortage of diamorphine 5mg injection. For more info click here
28/05/2019 |
|
|
|
|
|
The Trust is using a new clozapine assay service - click here for further details.
01/04/2019 |
|
|
|
|
|
Flupentixol depot supply problems - generic flupentixol (Psytixol - all strengths) has been out of stock since the end of January. However, the branded version - Depixol - remains available and the manufacturer has confirmed that there is no supply problem with this preparation.
26/02/2019 |
|
|
|
|
|
An update is available for mobile NetFormulary App users. Instructions are available for updating your app by clicking here.
03/12/2018 |
|
|
|
|
|
Clomipramine shortage update: 25mg and 50mg capsules are now available. the 10mg capsule is unavailable and stock not expected until June 2019.
29/11/2018 |
|
|
|
|
|
There is a temporary shortage of UK-licensed lorazepam injection. For information on the alternative being supplied to wards during the shortage, please click here.
08/11/2018 |
|
|
|
|
|
A temporary interruption of the supply of Epanutin (phenytoin) 30mg/5ml oral suspension, which may last until early December 2018, has been announced by Pfizer.
23/10/2018 |
|
|
|
|
|
OH Medicines Safety Action Note issued: Valproate Pregnancy Prevention Programme. Click here.
23/10/2018 |
|
|
|
|
|
Pharmacy and Dispensing Practice Q&A regarding adrenaline (Epipen and Epipen Junior) supply issue [NHS Gateway]: click here.
18/10/2018 |
|
|
|
|
|
Adrenaline auto-injector (Epipen) shortage - SUPPLY DISRUPTION ALERT. More details available here.
01/10/2018 |
|
|
|
|
|
Drugs & Therapeutics Group bullet point summary Jan - June 2018 available here.
06/09/2018 |
|
|
|
|
|
STOMP: Stopping OverMedication of Patients with a Learning Disability - NHS England encourages more to sign up to the STOMP pledge
08/05/2018 |
|
|
|
|
|
Valproate banned without the Pregnancy Prevention Programme
24/04/2018 |
|
|
|
|
|
Drugs & Therapeutics Group Bullet Points 2017/2018 available here.
19/03/2018 |
|
|
|
|
|
.
19/03/2018 |
|
|
|
|
|
Clozapine: reminder of potentially fatal risk of intestinal obstruction, faecal impaction, and paralytic ileus. Click here.
30/10/2017 |
|
|
|
|
|
-----------------
30/10/2017 |
|
|
|
|
|
Revised Alcohol Detox Guideline now available. click here.
14/10/2017 |
|
|
|
|
|
.
14/10/2017 |
|
|
|
|
|
There is a national shortage of Hepatitis B vaccine - for recommendations during supply constraints click here
08/08/2017 |
|
|
|
|
|
------------------------
08/08/2017 |
|
|
|
|
|
Drug Misuse and Dependence - updated guidance now available from the Department of Health. Click here.
18/07/2017 |
|
|
|
|
|
.
18/07/2017 |
|
|
|
|
|
Quetiapine - there is a shortage of generic immediate release quetiapine tablets. For further information and advice about alternative formulations please click here.
10/07/2017 |
|
|
|
|
|
.
10/07/2017 |
|
|
|
|
|
Olanzapine - there is a shortage of generic olanzapine tablets. For further information and advice about alternative formulations please click here.
10/07/2017 |
|
|
|
|
|
.
10/07/2017 |
|
|
|
|
|
Drugs & Therapeutics Group bullet points January 2017. Click here.
10/04/2017 |
|
|
|
|
|
.
10/04/2017 |
|
|
|
|
|
PATIENT SAFETY ALERT: Resources to support the safety of girls and women who are being treated with valproate, April 2017. Click here.
10/04/2017 |
|
|
|
|
|
.
10/04/2017 |
|
|
|
|
|
MHRA launch pilot reporting scheme for harms associated with illicit drugs, particularly new psychoactive substances. Click here.
23/03/2017 |
|
|
|
|
|
.
23/03/2017 |
|
|
|
|
|
Drugs & Therapeutics Group Bullet Point round up of formulary and prescribing decisions from 2016 Click here
20/02/2017 |
|
|
|
|
|
.
20/02/2017 |
|
|
|
|
|
Update about BNF numbering system: implications for T2 and T3 paperwork
16/01/2017 |
|
|
|
|
|
.
16/01/2017 |
|
|
|
|
|
There is a temporary shortage of fluphenazine depot. For more information click here
16/05/2016 |
|
|
|
|
|
.
16/05/2016 |
|
|
|
|
|
January DTG bullet points - vortioxetine, anti-inflammatories for schizophrenia, BNF numbering, lithium app, PGDs. Click here.
29/02/2016 |
|
|
|
|
|
29/02/2016 |
|
|
|
|
|
New Medicines Information Bulletin available - "Medicines and the Mental Health Act: frequently asked questions" click here.
29/02/2016 |
|
|
|
|
|
29/02/2016 |
|
|
|
|
|
BNF numbering system - where has it gone? Click here
16/02/2016 |
|
|
|
|
|
16/02/2016 |
|
|
|
|
|
Valproate and pregnancy - new toolkit launched to help patients better understand the risks. Click here.
10/02/2016 |
|
|
|
|
|
10/02/2016 |
|
|
|
|
|
Drugs & Therapeutics Group Bullet Points round up of formulary and prescribing decisions from 2015 Click here
06/01/2016 |
|
|
|
|
|
.
06/01/2016 |
|
|
|
|
|
Information about the new BNF layout Click here
30/11/2015 |
|
|
|
|
|
.
30/11/2015 |
|
|
|
|
|
DRUG SAFETY UPDATE: Mirabegron now contraindicated in severe uncontrolled hypertension Click here.
19/10/2015 |
|
|
|
|
|
.
19/10/2015 |
|
|
|
|
|
DRUG SAFETY UPDATE (Sept 2015): Proton Pump Inhibitors - very low risk of subacute cutaneous lupus erythematosus. Click here.
15/09/2015 |
|
|
|
|
|
15/09/2015 |
|
|
|
|
|
DRUG SAFETY UPDATE: High dose ibuprofen (≥2400mg/day): small increase in cardiovascular risk Click here.
01/07/2015 |
|
|
|
|
|
01/07/2015 |
|
|
|
|
|
DRUG SAFETY UPDATE: SGLT2 inhibitors: risk of diabetic ketoacidosis. Click here.
01/07/2015 |
|
|
|
|
|
01/07/2015 |
|
|
|
|
|
On 1st June the Misuse of Drugs Regulations were amended such that prescription writing requirements now apply to TEMAZEPAM.
16/06/2015 |
|
|
|
|
|
DRUG SAFETY UPDATE: Codeine for cough & cold - restricted use in children.
Click here.
02/06/2015 |
|
|
|
|
|
DRUG SAFETY UPDATE - Hydroxyzine: new QT risk warnings and new maximum doses. Click here.
02/06/2015 |
|
|
|
|
|
Your new formulary and prescribing guideline is on its way.... watch this space
30/04/2015 |
|
|
|
|
